Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis Biogen Idec, 31 May 2006 Accessed on 4 Jan 2012 from http://www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=862060. CommentRecommendBookmarkWatch
